# Maxwell B. Sauder, M.D. – FDA Inspection, Apr 6, 2023

Source: https://www.keypedia.com/records/fda_inspections/maxwell-b-sauder-md/7f831911-f213-4a84-b633-cb9aba036f2a
Source feed: FDA_Inspections

> FDA inspection 1202586 of Maxwell B. Sauder, M.D., April 06, 2023. Classification: Voluntary Action Indicated (VAI). Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1202586
- Company Name: Maxwell B. Sauder, M.D.
- Inspection Date: 2023-04-06
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/lakecha-n-lewis/39b6305d-2a9f-448b-9a14-e412b43c8522)

Company: https://www.keypedia.com/companies/maxwell-b-sauder-md/5f7f7eb3-a8c2-4e93-9de7-0fdc85430bd8

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
